Toward the full potential of mRNA therapeutics
Mol Ther
.
2024 Jun 5;32(6):1600-1601.
doi: 10.1016/j.ymthe.2024.05.012.
Epub 2024 May 23.
Authors
James O McNamara 2nd
1
,
Paloma H Giangrande
2
Affiliations
1
Nuclease Probe Technologies Inc., Lowell, MA 01852, USA.
2
Eleven Therapeutics, Inc., Cambridge, MA 02139, USA. Electronic address: paloma@eleventx.com.
PMID:
38788709
PMCID:
PMC11184373
DOI:
10.1016/j.ymthe.2024.05.012
No abstract available
Publication types
Editorial
MeSH terms
Animals
Genetic Therapy / methods
Humans
RNA, Messenger* / genetics
Substances
RNA, Messenger